Safety and Immunogenicity of the Heterologous 2-Dose Ad26.ZEBOV, MVA-BN-Filo Vaccine Regimen in Health Care Providers and Frontliners of the Democratic Republic of the Congo.
J Infect Dis
; 229(4): 1068-1076, 2024 Apr 12.
Article
in En
| MEDLINE
| ID: mdl-37673423
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Smallpox Vaccine
/
Hemorrhagic Fever, Ebola
/
Ebola Vaccines
/
Ebolavirus
Type of study:
Clinical_trials
Limits:
Animals
/
Humans
Country/Region as subject:
Africa
Language:
En
Journal:
J Infect Dis
Year:
2024
Document type:
Article